Evidence map›Paper›PMID 34029242›Full record

ReviewCornea2021

Herpes Zoster: A Brief Definitive Review.

Elisabeth J Cohen, Bennie H Jeng

Open access · greenAbstract readReview
In one paragraph

Review in Cornea, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. [Safety and efficacy of pulsed radiofrequency therapy for zoster-associated trigeminal neuralgia under general anesthesia].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Elisabeth J CohenDepartment of Ophthalmology, NYU Langone Health, New York, NY; and.
Bennie H JengDepartment of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD.
NYU Langone Health · USUniversity of Maryland, Baltimore · US

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
Long-term Suppressive Valacyclovir Treatment for Herpes Zoster OphthalmicusU10EY026869 · NEI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COHEN, ELISABETH J, HOCHMAN, JUDITH S · 2016 to 2023
$20.0M
NCATS NIH HHS UL1 TR001445NEI NIH HHS U10 EY026869
6 · The paper itself

Abstract

abstractThis brief definitive review of herpes zoster (HZ) will cover the current state of knowledge and questions that remain to be answered regarding HZ in general and HZ ophthalmicus in particular. A question-and-answer format will be used to address various important topics related to this common and serious disease. Questions to be addressed relate to common misconceptions, contagiousness of infection, unknowns regarding pathogenesis, rising incidence, risk factors and complications, relationship with temporal arteritis, vaccination, and current and future antiviral treatment. In addition, the importance of the Zoster Eye Disease Study to determine the efficacy of suppressive valacyclovir treatment in preventing complications of HZ ophthalmicus and the need to support enrollment will be discussed.

Indexed as

Antiviral AgentsEye Infections, ViralGlobal HealthHerpes ZosterHerpes Zoster OphthalmicusHerpes Zoster VaccineHumansIncidenceRNA, ViralVaccinationAntiviral AgentsHerpes Zoster VaccineRNA, Viral

Identifiers

PMID34029242
PMCPMC8249351
OpenAlexW3164932661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.